Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Bartoe

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Equine Veterinary Journal|June 24, 2011
Phacoemulsification and implantation of foldable +14 diopter intraocular lenses in five mature horsesW M Townsend, S Jacobi, J T Bartoe
Journal of Virology|November 9, 2000
Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promotersW Zhang, J W Nisbet, J T Bartoe, et al.
Journal of Virology|September 18, 2001
Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300W Zhang, J W Nisbet, B Albrecht, et al.
Journal of Virology|January 11, 2000
Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivoJ T Bartoe, B Albrecht, N D Collins, et al.
AIDS Research and Human Retroviruses|November 18, 2000
In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and IIM D Lairmore, B Albrecht, C D'Souza, et al.
Molecular Vision|September 17, 2009
AAV retinal transduction in a large animal model species: comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vectorS M Petersen-Jones, J T Bartoe, A J Fischer, et al.
Gene Therapy|July 25, 2014
Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trialsA L Minella, F M Mowat, K L Willett, et al.
Gene Therapy|November 15, 2013
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approachF M Mowat, K R Gornik, A Dinculescu, et al.
Gene Therapy|August 13, 2010
Gene therapy in the second eye of RPE65-deficient dogs improves retinal functionM J Annear, J T Bartoe, S E Barker, et al.
Gene Therapy|April 8, 2016
Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogsR F Boyd, D G Sledge, S L Boye, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Equine Veterinary Journal|June 24, 2011
Phacoemulsification and implantation of foldable +14 diopter intraocular lenses in five mature horsesW M Townsend, S Jacobi, J T Bartoe
Journal of Virology|November 9, 2000
Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promotersW Zhang, J W Nisbet, J T Bartoe, et al.
Journal of Virology|September 18, 2001
Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300W Zhang, J W Nisbet, B Albrecht, et al.
Journal of Virology|January 11, 2000
Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivoJ T Bartoe, B Albrecht, N D Collins, et al.
AIDS Research and Human Retroviruses|November 18, 2000
In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and IIM D Lairmore, B Albrecht, C D'Souza, et al.
Molecular Vision|September 17, 2009
AAV retinal transduction in a large animal model species: comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vectorS M Petersen-Jones, J T Bartoe, A J Fischer, et al.
Gene Therapy|July 25, 2014
Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trialsA L Minella, F M Mowat, K L Willett, et al.
Gene Therapy|November 15, 2013
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approachF M Mowat, K R Gornik, A Dinculescu, et al.
Gene Therapy|August 13, 2010
Gene therapy in the second eye of RPE65-deficient dogs improves retinal functionM J Annear, J T Bartoe, S E Barker, et al.
Gene Therapy|April 8, 2016
Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogsR F Boyd, D G Sledge, S L Boye, et al.
Pageof 2